ERASCA INC's ticker is and the CUSIP is 29479A108. A total of 88 filers reported holding ERASCA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $233,071 | -24.7% | 118,310 | +5.5% | 0.00% | – |
| Q2 2023 | $309,644 | -47.2% | 112,190 | -42.4% | 0.00% | – |
| Q1 2023 | $586,017 | -93.2% | 194,690 | -90.2% | 0.00% | -100.0% |
| Q4 2022 | $8,598,299 | -73.4% | 1,994,965 | -51.8% | 0.00% | -75.0% |
| Q3 2022 | $32,316,000 | +42.7% | 4,143,124 | +1.9% | 0.02% | +60.0% |
| Q2 2022 | $22,647,000 | -22.4% | 4,065,829 | +19.8% | 0.01% | -9.1% |
| Q1 2022 | $29,186,000 | -42.5% | 3,393,731 | +4.2% | 0.01% | -38.9% |
| Q4 2021 | $50,739,000 | -5.4% | 3,256,646 | +28.9% | 0.02% | -14.3% |
| Q3 2021 | $53,624,000 | – | 2,527,031 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 11,055,554 | $47,649,438 | 12.20% |
| EDBI Pte Ltd | 888,888 | $3,831,107 | 4.88% |
| Cormorant Asset Management, LP | 10,813,246 | $46,605 | 3.12% |
| AH Equity Partners LSV II, L.L.C. | 312,500 | $1,346,875 | 1.64% |
| GREAT POINT PARTNERS LLC | 1,538,461 | $6,630,767 | 1.30% |
| Artal Group S.A. | 4,710,682 | $20,303 | 1.13% |
| PFM Health Sciences, LP | 4,797,460 | $20,677,053 | 0.74% |
| Ghisallo Capital Management LLC | 929,316 | $4,005,352 | 0.71% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 462,972 | $1,995,409 | 0.38% |
| CVI Holdings, LLC | 376,716 | $1,623,646 | 0.21% |